Coronary artery disease as the cause of incident heart failure in the population

European Heart Journal

Volumn 22, Issue 3, 2001, Pages 228-236

  Fox, Kevin F ^a   Cowie, M R ^a   Wood, D A ^a   Coats, A J S ^a   Gibbs, J S R ^b   Underwood, S R ^a   Turner, R M ^c   Poole Wilson, P A ^a   Davies, S W ^a   Sutton, G C ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary disease; Epidemiology; Heart failure; Hibernation

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL HIBERNATION; POPULATION RESEARCH; PRIORITY JOURNAL; REVASCULARIZATION; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL STUNNING;

EID: 0034945990     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2289     Document Type: Article

References (24)

1. The epidemiology of heart failure
2. Incidence and aetiology of heart failure: A population study
3. Epidemiology of heart failure in the United States
4. Trends in hospitalization for heart failure in Scotland 1980-1990
5. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993
6. Survey on heart failure in Italian hospital cardiology units
7. Reversibility of cardiac wall motion abnormalities predicted by positron tomography
8. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularisation
9. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularisation in patients with coronary artery disease
10. The natural history of congestive heart failure: The Framingham study
11. Incidence of heart failure in eastern Finland: A population-based surveillance study
12. Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy
13. The Task Force on Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis of heart failure
14. Dobutamine echocardiography and Thallium-201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction
15. Differentiation between primary dilated cardiomyopathy and ischaemic cardiomyopathy based on right ventricular performance
16. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-Sestamibi with thallium reinjection and [18F] Fluorodeoxyglucose
17. Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: Differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction
18. Assessment of tissue viability: Clinical demand and problems
19. Rest Technetium-99m Sestamibi Tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of post-revascularisation outcome of asynergic territories
20. Effects of nitroglycerin by Technesium-99m Sestamibi Tomoscintography on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction
21. F18-Fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization
22. An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery
23. A randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
24. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease